Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Roadmap
  • Published:

Towards a reference cell atlas of liver diversity over the human lifespan

An Author Correction to this article was published on 23 October 2025

This article has been updated

Abstract

The goal of the Human Liver Cell Atlas (HLiCA) is to create a comprehensive map that defines the normal functions of diverse liver cell types and their spatial relationships over the human lifespan. This project fits within the goals of the Human Cell Atlas to create comprehensive reference maps of all human cells as a basis for both understanding human health and diagnosing, monitoring and treating disease. Through collection of samples from diverse individuals, data integration across technologies and overcoming liver-specific challenges for experimental methods, the HLiCA will map as many cell types and states as possible in healthy human livers from individuals across all ages and many ancestries. Establishing this HLiCA of healthy livers is a critical step to begin to understand perturbations in disease. The HLiCA will be available on an open-access platform to facilitate data sharing and dissemination. We expect that creation of the HLiCA will help to lay the foundation for new research initiatives to advance our understanding of liver disease, improve methods of tissue engineering, and identify novel prognostic biomarkers and therapies to improve patient outcomes. We describe key experimental and computational challenges to overcome in building the atlas and the potential impact of the atlas on disease research.

Key points

  • Building the Human Liver Cell Atlas requires collaborative effort within the liver single-cell genomics community.

  • Characterization of the normal human liver must account for sample-to-sample variability due to age, gender, ancestry, lifestyle, microbiome, environmental factors and experimental approaches, among other factors.

  • Collecting standardized metadata and optimizing data integration is critical to generate a useful and comprehensive cell atlas across multiple laboratories and institutions.

  • The Human Liver Cell Atlas will provide the foundation for understanding disease-specific perturbations and hopefully identify cell-type-specific therapeutic strategies to reduce the global burden of liver disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Overview of human liver anatomy.
Fig. 2: Methods for single-cell analyses to build an atlas for healthy human liver cells.
Fig. 3: Proposed metadata to generate a comprehensive liver cell atlas.
Fig. 4: Single-cell technology can help to improve outcomes in human liver disease.

Similar content being viewed by others

Change history

References

  1. Moon, A. M., Singal, A. G. & Tapper, E. B. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin. Gastroenterol. Hepatol. 18, 2650–2666 (2020).

    Article  PubMed  Google Scholar 

  2. GBD 2017 Cirrhosis Collaborators The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol. Hepatol. 5, 245–266 (2020).

    Article  Google Scholar 

  3. Cheemerla, S. & Balakrishnan, M. Global epidemiology of chronic liver disease. Clin. Liver Dis. 17, 365–370 (2021).

    Article  Google Scholar 

  4. Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851–861 (2022).

    Article  CAS  PubMed  Google Scholar 

  5. Huang, D. Q., Mathurin, P., Cortez-Pinto, H. & Loomba, R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat. Rev. Gastroenterol. Hepatol. 20, 37–49 (2023).

    Article  PubMed  Google Scholar 

  6. Wong, R. J. & Singal, A. K. Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014-2019. JAMA Netw. Open 3, e1920294 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  7. World Health Organization. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2021 (WHO, 2021).

  8. Haga, J. et al. Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transpl. 14, 1718–1724 (2008).

    Article  PubMed  Google Scholar 

  9. Read, A. E. Clinical physiology of the liver. Br. J. Anaesth. 44, 910–917 (1972).

    Article  CAS  PubMed  Google Scholar 

  10. Trefts, E., Gannon, M. & Wasserman, D. H. The liver. Curr. Biol. 27, R1147–R1151 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kiernan, F. XXIX. The anatomy and physiology of the liver. Phil. Trans. R. Soc. 123, 711–770 (1833).

    Article  Google Scholar 

  12. Arias, I. M. et al. The Liver: Biology and Pathobiology (Wiley, 2020).

  13. Jungermann, K. & Kietzmann, T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu. Rev. Nutr. 16, 179–203 (1996).

    Article  CAS  PubMed  Google Scholar 

  14. Paris, J. & Henderson, N. C. Liver zonation, revisited. Hepatology 76, 1219–1230 (2022).

    Article  PubMed  Google Scholar 

  15. MacParland, S. A. et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat. Commun. 9, 4383 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512–518 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Aizarani, N. et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 572, 199–204 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Sharma, A. et al. Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma. Cell 183, 377–394.e21 (2020).

    Article  CAS  PubMed  Google Scholar 

  19. Andrews, T. S. et al. Single-cell, single-nucleus, and spatial RNA sequencing of the human liver identifies cholangiocyte and mesenchymal heterogeneity. Hepatol. Commun. 6, 821–840 (2022).

    Article  CAS  PubMed  Google Scholar 

  20. Parlakgul, G. et al. Regulation of liver subcellular architecture controls metabolic homeostasis. Nature 603, 736–742 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Walsh, C. L. et al. Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography. Nat. Methods 18, 1532–1541 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Consortium, M. I. Functional connectomics spanning multiple areas of mouse visual cortex. Nature 640, 435–447 (2025).

    Article  Google Scholar 

  23. Watson, B. R. et al. Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution. Nat. Commun. 16, 319 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Waxman, D. J. & O’Connor, C. Growth hormone regulation of sex-dependent liver gene expression. Mol. Endocrinol. 20, 2613–2629 (2006).

    Article  CAS  PubMed  Google Scholar 

  25. Jaffe, C. A. et al. Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J. Clin. Invest. 102, 153–164 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kaplan, M. M. & Gershwin, M. E. Primary biliary cirrhosis. N. Engl. J. Med. 353, 1261–1273 (2005).

    Article  CAS  PubMed  Google Scholar 

  27. Lin, L. et al. The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, national, age, and sex level results from the Global Burden of Disease Study 2017. Liver Cancer 9, 563–582 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  28. Targher, G., Byrne, C. D. & Tilg, H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73, 691–702 (2024).

    Article  CAS  PubMed  Google Scholar 

  29. Niriella, M. A. et al. Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the south Asian region: a meta-analysis. Lancet Reg. Health Southeast Asia 15, 100220 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  30. Vendhan, R. et al. Comparison of characteristics between nonobese and overweight/obese subjects with nonalcoholic fatty liver disease in a South Indian population. Diabetes Technol. Ther. 16, 48–55 (2014).

    Article  CAS  PubMed  Google Scholar 

  31. Peiseler, M. et al. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease — novel insights into cellular communication circuits. J. Hepatol. 77, 1136–1160 (2022).

    Article  CAS  PubMed  Google Scholar 

  32. Lombardi, R., Iuculano, F., Pallini, G., Fargion, S. & Fracanzani, A. L. Nutrients, genetic factors, and their interaction in non-alcoholic fatty liver disease and cardiovascular disease. Int. J. Mol. Sci. 21, 8761 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lakshminarayanan, B. & Davenport, M. Biliary atresia: a comprehensive review. J. Autoimmun. 73, 1–9 (2016).

    Article  PubMed  Google Scholar 

  34. Mann, D. A. Epigenetics in liver disease. Hepatology 60, 1418–1425 (2014).

    Article  CAS  PubMed  Google Scholar 

  35. Bolshette, N., Ibrahim, H., Reinke, H. & Asher, G. Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology. Nat. Rev. Gastroenterol. Hepatol. 20, 695–707 (2023).

    Article  PubMed  Google Scholar 

  36. Duane, W. C., Levitt, D. G., Mueller, S. M. & Behrens, J. C. Regulation of bile acid synthesis in man. Presence of a diurnal rhythm. J. Clin. Invest. 72, 1930–1936 (1983).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. March, S. et al. Autonomous circadian rhythms in the human hepatocyte regulate hepatic drug metabolism and inflammatory responses. Sci. Adv. 10, eadm9281 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Narmada, B. C. et al. Single cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity. J. Hepatol. 81, 42–61 (2024).

    Article  CAS  PubMed  Google Scholar 

  39. Lotto, J., Stephan, T. L. & Hoodless, P. A. Fetal liver development and implications for liver disease pathogenesis. Nat. Rev. Gastroenterol. Hepatol. 20, 561–581 (2023).

    Article  PubMed  Google Scholar 

  40. Wesley, B. T. et al. Single-cell atlas of human liver development reveals pathways directing hepatic cell fates. Nat. Cell Biol. 24, 1487–1498 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Santos Silva, E. et al. Bile acids profile and redox status in healthy infants. Pediatr. Res. 93, 1856–1864 (2023).

    Article  CAS  PubMed  Google Scholar 

  42. Grijalva, J. & Vakili, K. Neonatal liver physiology. Semin. Pediatr. Surg. 22, 185–189 (2013).

    Article  PubMed  Google Scholar 

  43. Itoh, S. et al. Fetal and neonatal bilirubin metabolism. Front. Pediatr. 10, 1002408 (2022).

    Article  PubMed  Google Scholar 

  44. Edgar, R. D. et al. Single-cell atlas of human pediatric liver reveals age-related hepatic gene signatures. Hepatol. Commun. 9, e0813 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  45. Nobili, V., Alisi, A., Newton, K. P. & Schwimmer, J. B. Comparison of the phenotype and approach to pediatric vs adult patients with nonalcoholic fatty liver disease. Gastroenterology 150, 1798–1810 (2016).

    Article  PubMed  Google Scholar 

  46. Ben-Moshe, S. & Itzkovitz, S. Spatial heterogeneity in the mammalian liver. Nat. Rev. Gastroenterol. Hepatol. 16, 395–410 (2019).

    Article  PubMed  Google Scholar 

  47. Nobili, V. et al. A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease. Arch. Dis. Child. 94, 801–805 (2009).

    Article  CAS  PubMed  Google Scholar 

  48. Park, Y. et al. The association between breastfeeding and nonalcoholic fatty liver disease in parous women: a nation-wide cohort study. Hepatology 74, 2988–2997 (2021).

    Article  PubMed  Google Scholar 

  49. Eom, J. A. et al. Diet-regulating microbiota and host immune system in liver disease. Int. J. Mol. Sci. 22, 6326 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Yang, X. et al. The gut–liver axis in immune remodeling: new insight into liver diseases. Int. J. Biol. Sci. 16, 2357–2366 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Schreiber, R. A., Harpavat, S., Hulscher, J. B. F. & Wildhaber, B. E. Biliary atresia in 2021: epidemiology, screening and public policy. J. Clin. Med. 11, 999 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Wang, J. et al. Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia. Cell 183, 1867–1883.e26 (2020).

    Article  CAS  PubMed  Google Scholar 

  53. Taylor, S. A. et al. Transcriptional profiling of pediatric cholestatic livers identifies three distinct macrophage populations. PLoS ONE 16, e0244743 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Gebhardt, R. Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol. Ther. 53, 275–354 (1992).

    Article  CAS  PubMed  Google Scholar 

  55. Rappaport, A. M., Borowy, Z. J., Lougheed, W. M. & Lotto, W. N. Subdivision of hexagonal liver lobules into a structural and functional unit; role in hepatic physiology and pathology. Anat. Rec. 119, 11–33 (1954).

    Article  CAS  PubMed  Google Scholar 

  56. Halpern, K. B. et al. Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature 542, 352–356 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Manco, R. & Itzkovitz, S. Liver zonation. J. Hepatol. 74, 466–468 (2021).

    Article  CAS  PubMed  Google Scholar 

  58. Cheng, X. et al. Glucagon contributes to liver zonation. Proc. Natl Acad. Sci. USA 115, E4111–E4119 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Halpern, K. B. et al. Paired-cell sequencing enables spatial gene expression mapping of liver endothelial cells. Nat. Biotechnol. 36, 962–970 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Dobie, R. et al. Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis. Cell Rep. 29, 1832–1847.e8 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Hu, S. et al. Single-cell spatial transcriptomics reveals a dynamic control of metabolic zonation and liver regeneration by endothelial cell Wnt2 and Wnt9b. Cell Rep. Med. 3, 100754 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Zhao, L. et al. Tissue repair in the mouse liver following acute carbon tetrachloride depends on injury-induced Wnt/β-catenin signaling. Hepatology 69, 2623–2635 (2019).

    Article  CAS  PubMed  Google Scholar 

  63. Planas-Paz, L. et al. The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. Nat. Cell Biol. 18, 467–479 (2016).

    Article  CAS  PubMed  Google Scholar 

  64. Gola, A. et al. Commensal-driven immune zonation of the liver promotes host defence. Nature 589, 131–136 (2021).

    Article  CAS  PubMed  Google Scholar 

  65. Sakai, M. et al. Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain Kupffer cell identity. Immunity 51, 655–670.e8 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Bonnardel, J. et al. Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche. Immunity 51, 638–654.e9 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Guilliams, M. et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell 185, 379–396.e38 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Remmerie, A. et al. Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver. Immunity 53, 641–657.e14 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Seidman, J. S. et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity 52, 1057–1074.e7 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Balmer, M. L. et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci. Transl. Med. 6, 237ra266 (2014).

    Article  Google Scholar 

  71. Brazovskaja, A. et al. Cell atlas of the regenerating human liver after portal vein embolization. Nat. Commun. 15, 5827 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Matchett, K. P. et al. Multimodal decoding of human liver regeneration. Nature 630, 158–165 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Gribben, C. et al. Acquisition of epithelial plasticity in human chronic liver disease. Nature 630, 166–173 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Chung, B. K., Ogaard, J., Reims, H. M., Karlsen, T. H. & Melum, E. Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis. Hepatol. Commun. 6, 2538–2550 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Buonomo, E. L. et al. Liver stromal cells restrict macrophage maturation and stromal IL-6 limits the differentiation of cirrhosis-linked macrophages. J. Hepatol. 76, 1127–1137 (2022).

    Article  CAS  PubMed  Google Scholar 

  76. Filliol, A. et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature 610, 356–365 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Kajiyama, K., Maeda, T., Takenaka, K., Sugimachi, K. & Tsuneyoshi, M. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of ‘scirrhous-type’ and ‘nonscirrhous-type’ growth. Am. J. Surg. Pathol. 23, 892–902 (1999).

    Article  CAS  PubMed  Google Scholar 

  78. Sirica, A. E. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 9, 44–54 (2011).

    Article  PubMed  Google Scholar 

  79. Affo, S. et al. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 39, 866–882.e11 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Jagadeesh, K. A. et al. Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics. Nat. Genet. 54, 1479–1492 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829–845.e20 (2019).

    Article  CAS  PubMed  Google Scholar 

  82. Korsunsky, I. et al. Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases. Med 3, 481–518.e14 (2022).

    Article  CAS  PubMed  Google Scholar 

  83. Muhl, L. et al. Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination. Nat. Commun. 11, 3953 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Genshaft, A. S. et al. Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients. Hepatology 78, 1525–1541 (2023).

    Article  PubMed  Google Scholar 

  85. Habib, N. et al. Massively parallel single-nucleus RNA-seq with DroNc-seq. Nat. Methods 14, 955–958 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865–868 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Atif, J., Thoeni, C., Bader, G. D., McGilvray, I. D. & MacParland, S. A. Unraveling the complexity of liver disease one cell at a time. Semin. Liver Dis. 42, 250–270 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Cheng, M. et al. Spatially resolved transcriptomics: a comprehensive review of their technological advances, applications, and challenges. J. Genet. Genom. 50, 625–640 (2023).

    Article  Google Scholar 

  89. Luecken, M. D. et al. Benchmarking atlas-level data integration in single-cell genomics. Nat. Methods 19, 41–50 (2022).

    Article  CAS  PubMed  Google Scholar 

  90. Young, M. D. & Behjati, S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. Gigascience 9, giaa151 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  91. Lahnemann, D. et al. Eleven grand challenges in single-cell data science. Genome Biol. 21, 31 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  92. Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D. & Marioni, J. C. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 40, 245–253 (2022).

    Article  CAS  PubMed  Google Scholar 

  93. Koussounadis, A., Langdon, S. P., Um, I. H., Harrison, D. J. & Smith, V. A. Relationship between differentially expressed mRNA and mRNA–protein correlations in a xenograft model system. Sci. Rep. 5, 10775 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  94. Repapi, E., Agarwal, D., Napolitani, G., Sims, D. & Taylor, S. Integration of single-cell RNA-Seq and CyTOF data characterises heterogeneity of rare cell subpopulations. F1000Res. 11, 560 (2023).

    Article  Google Scholar 

  95. Black, S. et al. CODEX multiplexed tissue imaging with DNA-conjugated antibodies. Nat. Protoc. 16, 3802–3835 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Clarke, G. M. et al. A novel, automated technology for multiplex biomarker imaging and application to breast cancer. Histopathology 64, 242–255 (2014).

    Article  PubMed  Google Scholar 

  97. Gerdes, M. J. et al. Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue. Proc. Natl Acad. Sci. USA 110, 11982–11987 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Xie, R. et al. Spatially resolved gene expression prediction from histology images via bi-modal contrastive learning. In Adv. Neural Inf. Process. Syst. 36 (NeurIPS, 2023).

  99. Lunger, I., Fawaz, M. & Rieger, M. A. Single-cell analyses to reveal hematopoietic stem cell fate decisions. FEBS Lett. 591, 2195–2212 (2017).

    Article  CAS  PubMed  Google Scholar 

  100. Wagner, D. E. & Klein, A. M. Lineage tracing meets single-cell omics: opportunities and challenges. Nat. Rev. Genet. 21, 410–427 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Brand, M. & Morrissey, E. Single-cell fate decisions of bipotential hematopoietic progenitors. Curr. Opin. Hematol. 27, 232–240 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  102. Cunningham, R. P. & Porat-Shliom, N. Liver zonation — revisiting old questions with new technologies. Front. Physiol. 12, 732929 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  103. Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281–291.e9 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Kudryavtsev, B. N., Kudryavtseva, M. V., Sakuta, G. A. & Stein, G. I. Human hepatocyte polyploidization kinetics in the course of life cycle. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 64, 387–393 (1993).

    Article  CAS  PubMed  Google Scholar 

  105. Kiselev, V. Y., Andrews, T. S. & Hemberg, M. Challenges in unsupervised clustering of single-cell RNA-seq data. Nat. Rev. Genet. 20, 273–282 (2019).

    Article  CAS  PubMed  Google Scholar 

  106. Zhang, J. M., Kamath, G. M. & Tse, D. N. Valid post-clustering differential analysis for single-cell RNA-Seq. Cell Syst. 9, 383–392.e6 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Kim, M. & Costello, J. DNA methylation: an epigenetic mark of cellular memory. Exp. Mol. Med. 49, e322 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Kim, M. S. et al. A draft map of the human proteome. Nature 509, 575–581 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Hu, C. CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 51, D870–D876 (2023).

    Article  CAS  PubMed  Google Scholar 

  110. Osumi-Sutherland, D. et al. Cell type ontologies of the human cell atlas. Nat. Cell Biol. 23, 1129–1135 (2021).

    Article  CAS  PubMed  Google Scholar 

  111. Wang, S. et al. An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis. Sci. Transl. Med. 15, eadd3949 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Fred, R. G. et al. Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis. Sci. Rep. 12, 13484 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Poch, T. et al. Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis. J. Hepatol. 75, 414–423 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Ye, C. et al. Single-cell and spatial transcriptomics reveal the fibrosis-related immune landscape of biliary atresia. Clin. Transl. Med. 12, e1070 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Song, G. et al. Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma. Nat. Commun. 13, 1642 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Huang, H. et al. Single-cell transcriptomics uncovers cellular architecture and developmental trajectories in hepatoblastoma. Hepatology 77, 1911–1928 (2023).

    Article  PubMed  Google Scholar 

  117. Wang, X. et al. Comparative analysis of cell lineage differentiation during hepatogenesis in humans and mice at the single-cell transcriptome level. Cell Res. 30, 1109–1126 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Massalha, H. et al. A single cell atlas of the human liver tumor microenvironment. Mol. Syst. Biol. 16, e9682 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Chalasani, N. et al. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J. Hepatol. 48, 829–834 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  120. Schwen, L. O. et al. Zonated quantification of steatosis in an entire mouse liver. Comput. Biol. Med. 73, 108–118 (2016).

    Article  PubMed  Google Scholar 

  121. Alexandrov, T. Spatial metabolomics: from a niche field towards a driver of innovation. Nat. Metab. 5, 1443–1445 (2023).

    Article  PubMed  Google Scholar 

  122. Deng, Y. et al. Spatial profiling of chromatin accessibility in mouse and human tissues. Nature 609, 375–383 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Xu, H. et al. SPACEL: deep learning-based characterization of spatial transcriptome architectures. Nat. Commun. 14, 7603 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Almagro-Pérez, C. et al. AI-driven 3D spatial transcriptomics. Preprint at https://arxiv.org/abs/2502.17761 (2025).

  125. Lotfollahi, M. et al. Mapping single-cell data to reference atlases by transfer learning. Nat. Biotechnol. 40, 121–130 (2022).

    Article  CAS  PubMed  Google Scholar 

  126. Xu, C. et al. Probabilistic harmonization and annotation of single-cell transcriptomics data with deep generative models. Mol. Syst. Biol. 17, e9620 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  127. Brbic, M. et al. MARS: discovering novel cell types across heterogeneous single-cell experiments. Nat. Methods 17, 1200–1206 (2020).

    Article  CAS  PubMed  Google Scholar 

  128. Song, H. et al. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. Nat. Commun. 13, 4878 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. CZI Cell Science Program et al. CZ CELLxGENE discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data. Nucleic Acids Res. 53, D886–D900 (2025).

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank F. Hamade, biomedical illustrator, for creating the initial draft of the figures. They thank the HCA executive office, data portal and Lattice staff for outstanding project support. The HLiCA project is supported by funding from the Chan Zuckerberg Initiative (to S. A. Taylor, G.D.B., S.M., A.C.M., A.G.C., R.D., D.G., M.G., N.C.H., S.S.H., S.I., G.M.L., I.M., K.R.M., G.Q., A. Regev, A. Ricciuto, C.L.S., M.M.T., S. A. Teichmann, L.V., B.W. and M.Z.). Additional support was provided by the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) K08 grant DK121937 (to S. A. Taylor); NSERC Discovery grant RGPIN-2023-03419 and CIHR grant RN482632-481311 (to T.A.); CIHR grant PJT 180542 (to G.D.B.); CZI Seed Network grant CZIF2019-002429, Singapore National Medical Research Council (NMRC) grants NMRC/TCR/14-NUHS/2015 and NMRC/OFLCG19May-0038, and National Research Foundation grant (NRF-CRP) CRP26-2021-0005 (to R.D.); the Bundesministerium für Bildung und Forschung (BMBF) CureFib – 01EJ2201C (to D.G.); Ghent University BOF18-GOA-024 and BOF24/GOA/035 and FWO project grants 3G000519 and G013823N (to M.G.); Wellcome Trust Senior Research Fellowship in Clinical Science (ref. 219542/Z/19/Z) and the Medical Research Council (N.C.H.); R01DK132751 and R01DK120765 (S.S.H.); Helen and Martin Kimmel Award for Innovative Investigation, the Yad Abraham Research Center for Cancer Diagnostics and Therapy, the Moross Integrated Cancer Center, the Minerva Stiftung grant, a Weizmann-Sheba grant, the Israel Science Foundation grants no. 908/21 and 3663/21, the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme grant no. 768956 and a grant from the Ministry of Innovation, Science & Technology, Israel (to S.I.); Massachusetts Life Science Center (MLSC) and NIH grants R01AA030770 and K08 DK115883 (to Z.G.J); the ERC (MyeFattyLiver no. 851908) and FWO project grants 3G000519, G075923N and G0A9Z24N (to C.L.S.); CSL Centenary Fellowship and National Health and Medical Research Council (NHMRC) Ideas Grant 2021/GNT2010795 (to A.S.); NIDDK R21 grant DK127275-01 (to M.M.T.); Advanced grant NewChol (to L.V.); NHLBI U54 HL 165440-01 grant (to I.S.V.); Hector Foundation, Dieter Morszeck Foundation and the German Research Foundation (SFB 1479) (to M.R.).

Author information

Authors and Affiliations

Authors

Contributions

The authors contributed equally to writing and reviewing/editing the manuscript before submission. S. A. Taylor, G.D.B., S.M. and A.C.M. researched data for the article and contributed substantially to discussion of the content.

Corresponding authors

Correspondence to Gary D. Bader or Alan C. Mullen.

Ethics declarations

Competing interests

S. A. Taylor serves as a consultant for Ipsen Pharmaceutical. A.C.M. receives funding from GSK and Boehringer Ingelheim for unrelated projects. A.J.G. receives research funding from Aligos Therapeutics, Bluejay Therapeutics, GSK, Roche and Vir Biotechnology, and performs scientific advisory services for Aligos Therapeutics, Arbutus Biopharma, Assembly Biosciences, Bluejay Therapeutics, Gilead Sciences, GSK, Janssen Pharmaceuticals, Roche, Vir Biotechnology, Virion Therapeutics and VBI for unrelated projects. D.G. serves as a consultant for Gordian Biotechnology. M.G. receives funding from the Sanofi iTech Award programme for an unrelated project. N.C.H. has received research funding from AbbVie, Pfizer, Gilead and Boehringer-Ingelheim, and is an adviser or consultant for Astra-Zeneca, GSK and MSD. S.S.H serves as a consultant for ARNATAR Therapeutics. Z.G.J. serves on the advisory board of Olix Pharmaceuticals, and received grants from Pfizer and Gilead Sciences. A. Ricciuto receives a stipend for academic lectures from Janssen and Organon. C.L.S. receives funding from Novo Nordisk for unrelated projects. M.M.T has served as a consultant for Merck for an unrelated project. L.V. is a shareholder of Definigen, BiliTech and Bit.bio. I.S.V. consults for Guidepoint Global, Cowen and Mosaic. B.W. serves as a consultant for Alnylam Pharmaceuticals, Disc Medicine, Mitsubishi Tanabe Pharma and Recordati Rare Diseases. G.D.B. advises Adela Bio and BioRender. The other authors declare no competing interests.

Peer review

Peer review information

Nature Reviews Gastroenterology & Hepatology thanks the anonymous reviewers for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Related links

Cell Annotation Platform: https://celltype.info

CellMarker: http://117.50.127.228/CellMarker

CELL×GENE: https://cellxgene.cziscience.com

HCA community: https://www.humancellatlas.org/join-the-hca

Human Cell Atlas: https://www.humancellatlas.org

Human Liver Cell Atlas: https://www.humancellatlas.org/biological-networks/liver-biological-network

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taylor, S.A., Bader, G.D., MacParland, S. et al. Towards a reference cell atlas of liver diversity over the human lifespan. Nat Rev Gastroenterol Hepatol 23, 97–109 (2026). https://doi.org/10.1038/s41575-025-01114-3

Download citation

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41575-025-01114-3

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing